Expanded Access to Cyclic Irrigation in Patients Undergoing Exchange Arthroplasty

NCT06383611 · Status: TEMPORARILY_NOT_AVAILABLE · Type: EXPANDED_ACCESS

Last updated 2026-04-15

No results posted yet for this study

Summary

The objective of the protocol is to provide access to the VT-X7 (Vancomycin, Tobramycin Exchanged in 7 Days) system for subjects with periprosthetic joint infection (PJI) of the hip or knee who lack therapeutic treatment alternatives.

Conditions

  • Prosthetic-joint Infection

Interventions

COMBINATION_PRODUCT

VT-X7 Treatment System

Local antibiotic irrigation via the VT-X7 Treatment System adjuvant to two-stage exchange arthroplasty per standard of care.

Sponsors & Collaborators

  • Osteal Therapeutics, Inc.

    lead INDUSTRY

Eligibility

Min Age
22 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06383611 on ClinicalTrials.gov